These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4855951)

  • 1. Plasma levels of methsuximide and N-desmethylmethsuximide during methsuximide therapy.
    Strong JM; Abe T; Gibbs EL; Atkinson AJ
    Neurology; 1974 Mar; 24(3):250-5. PubMed ID: 4855951
    [No Abstract]   [Full Text] [Related]  

  • 2. Methsuximide for intractable childhood seizures.
    Tennison MB; Greenwood RS; Miles MV
    Pediatrics; 1991 Feb; 87(2):186-9. PubMed ID: 1987529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective and safe but forgotten: methsuximide in intractable epilepsies in childhood.
    Sigler M; Strassburg HM; Boenigk HE
    Seizure; 2001 Mar; 10(2):120-4. PubMed ID: 11407955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum protein binding of desmethyl-methsuximide.
    Wad N; Bourgeois B; Krämer G
    Clin Neuropharmacol; 1999; 22(4):239-40. PubMed ID: 10442255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Methsuximide in the treatment of epilepsies (author's transl)].
    Stenzel E; Boenigk HE; Rambeck B
    Nervenarzt; 1977 Jul; 48(7):377-82. PubMed ID: 578567
    [No Abstract]   [Full Text] [Related]  

  • 6. Gas-chromatographic analysis for succinimide anticonvulsants in serum: macro- and micro-scale methods.
    Bonitati J
    Clin Chem; 1976 Mar; 22(3):341-5. PubMed ID: 815062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a blood metabolite of methsuximide by GLC-mass spectrometry.
    Muni IA; Altshuler CH; Neicheril JC
    J Pharm Sci; 1973 Nov; 62(11):1820-3. PubMed ID: 4758080
    [No Abstract]   [Full Text] [Related]  

  • 8. Methsuximide for refractory complex partial seizures.
    Wilder BJ; Buchanan RA
    Neurology; 1981 Jun; 31(6):741-4. PubMed ID: 6894634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results in the treatment of epilepsy with Morfolep. The effects of Morfolep on partial seizures and generalized convulsive seizures.
    Volanschi D; Florescu D; Tudor S
    Rev Roum Neurol; 1971; 8(5):361-89. PubMed ID: 5140610
    [No Abstract]   [Full Text] [Related]  

  • 10. Monitoring drug concentrations in a case of combined overdosage with primidone and methsuximide.
    Johnson GF; Least CJ; Serum JW; Solow EB; Solomon HM
    Clin Chem; 1976 Jun; 22(6):915-21. PubMed ID: 946953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of N,2-dimethyl-2-phenylsuccinimide (methsuximide) by the epoxide-diol pathway in rat, guinea pig and human.
    Horning MG; Butler C; Harvey DJ; Hill RM; Zion TE
    Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):565-78. PubMed ID: 4750102
    [No Abstract]   [Full Text] [Related]  

  • 12. Methsuximide therapy of juvenile myoclonic epilepsy.
    Hurst DL
    Seizure; 1996 Mar; 5(1):47-50. PubMed ID: 8777552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of methsuximide and N-desmethylmethsuximide using solid-phase extraction and wide-bore capillary gas chromatography.
    Cardella DS; Levtzow CB; Rifai N; Cross RE; Howlett CM; Parker NC
    Clin Biochem; 1988 Dec; 21(6):329-31. PubMed ID: 3233745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contribution to succinimide therapy - experiences gained using Epimid "Spofa"].
    Lange E; Fuchs R; Kummer M
    Psychiatr Neurol Med Psychol (Leipz); 1966 Mar; 18(3):109-14. PubMed ID: 5983199
    [No Abstract]   [Full Text] [Related]  

  • 15. Analysis of desmethylmethsuximide using high-performance liquid chromatography.
    Streete JM; Berry DJ; Clarke LA; Newbery JE
    Ther Drug Monit; 1995 Jun; 17(3):280-6. PubMed ID: 7624925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorption, distribution and excretion of methsuximide in male rats.
    Nicholls PJ; Orton TC
    Br J Pharmacol; 1971 Oct; 43(2):459P-460P. PubMed ID: 5158235
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of epilepsy. The causes and consequences of inadequate treatment].
    Ritter G
    Dtsch Med Wochenschr; 1972 Oct; 97(41):1559-63. PubMed ID: 4403909
    [No Abstract]   [Full Text] [Related]  

  • 18. A comprehensive gas chromatographic scheme for the estimation of antiepileptic drugs.
    Gardner-Thorpe C; Parsonage MJ; Smethurst PF; Toothill C
    Clin Chim Acta; 1972 Jan; 36(1):223-30. PubMed ID: 4400016
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical and electroencephalographic evaluation of M-4 in the treatment of petit mal epilepsy].
    Kawiak W; Markiewicz M; Dylewska D; Darwaj B; Dudkowska A; Fuksiewicz K; Kolodziejczyk S
    Neurol Neurochir Pol; 1972; 6(5):755-9. PubMed ID: 4629344
    [No Abstract]   [Full Text] [Related]  

  • 20. Methsuximide reduces valproic acid serum levels.
    Besag FM; Berry DJ; Vasey M
    Ther Drug Monit; 2001 Dec; 23(6):694-7. PubMed ID: 11802106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.